Health Catalyst Reports First Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Health Catalyst (HCAT) Misses Q1 EPS by 22c, Offers Q2 Guidance
May 12, 2020 4:26 PM EDTHealth Catalyst (NASDAQ: HCAT) reported Q1 EPS of ($0.47), $0.22 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $45.1 million versus the consensus estimate of $43.47 million.
Financial Outlook:
Health Catalyst provides forward-looking guidance on total revenue, a GAAP... More
